Welcome to the Pathogenesys Web site. Our goal is to provide you with useful information about our company that we hope makes it easier for you to do business with us.

Pathogenesys serves the Pharmaceutical and Biotech industries by providing high quality, esoteric testing services during the conduct of pre-clinical drug development research or clinical trials. High value is added to drug development efforts through the conduct of research testing under GLP-compliant conditions, utilizing our experienced staff.  Our current menu of services includes technologies such as Immunohistochemistry, FISH, ELISA, analysis of minimal residual disease, cell culture and use of animal models.  Innovative development of additional proprietary technologies will also soon enhance our ability to deliver unique biomarker analysis.

At this site, you will discover all about our menu of services and capabilities, as well as our courteous and resourceful staff.

Feel free to browse around this site. If you have comments or questions about our products or services, or simply need more information and want to contact us, click on the contact button on any page within this site.

Thanks for visiting and we look forward to serving you.



James A. Thompson M.D. Ph.D. serves as CEO and Medical Director.  Jim has over 10 years of pathology and direct industry experience.

Jonathan H. Blanding serves as Vice President of Quality Assurance. John has over 20 years of technical, regulatory, and operational experience in the diagnostic, device and pharmaceutical industries.



James Thompson at 27126A Paseo Espada, Suite 1603, San Juan Capistrano, CA 92675          (949) 542-7755       (949) 542-7757fax     jthompson@pathogenesys.com


[Home] [About Us] [Mission Statement] [Services] [Proprietary Technologies] [Investment Opportunities] [FAQ] [News] [References] [Contractual Relationship] [Events] [Study Reporting]